Teva Pharm Expects About 25 Percent of EpiPen Market by Year End
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva leans on Ajovy and Austedo as revenues sink
Netanyahu asks Teva Pharm to minimize job loss in Israel | Reuters
Teva reaches proposed $4.35 bln settlement of U.S. opioid lawsuits | Reuters
Incoming Teva CEO Jeremy Levin (front) sits with Teva Chairman Phillip Frost (C) and outgoing CEO Shlomo Yanai during a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the
TEVA.TA - | Stock Price & Latest News | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
Teva Pharmaceutical meets forecasts, but 2023 outlook disappoints | Reuters
Averting opioid trial, Teva, drug distributors reach last-gasp settlement - The Jerusalem Post
GSK's $235 million verdict revived against Teva, again | Reuters
Rhode Island takes Teva to trial in multibillion-dollar opioid case | Business Insurance
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva to pay up to $4.2 billion in U.S. to settle opioid claims | Reuters